マーケットレポート詳細

インフルエンザ診断市場：2031年予測

Influenza Diagnostics Market (Test Type: RT-PCR Tests, Rapid Influenza Diagnostic Tests, Viral Culture, Immunofluorescence Assays, Serological Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版元：Transparency Market Research 　 出版元について
発行年：2023年12月
定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文172ページになります。
商品コード：TMR164

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

インフルエンザ診断の世界市場規模は2022年で13億ドル、2031年に20億ドル、市場の平均年成長率は5.6%になると予測されています。

当レポートでは、インフルエンザ診断の市場予測-2031年、各種セグメント別市場分析(検査タイプ別、製品タイプ別、国地域別、等)、COVID-19の影響分析、SWOT分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■インフルエンザ診断の世界市場予測2017-2031年

・市場規模(US$)

■インフルエンザウイルスタイプ別、市場-2031年

A型
B型
※(市場規模US$)

■検査タイプ別、市場-2031年

RT-PCR検査
迅速インフルエンザ診断検査 (RIDT)
ウイルス培養
免疫蛍光法
血清学的検査
その他（LAMP、SAMBAなど）
※(市場規模US$)

■製品タイプ別、市場-2031年

キット/試薬
機器
その他
※(市場規模US$)

■エンドユーザー別、市場-2031年

病院
診断センター
その他（学術・研究機関など）
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・スペイン、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス（促進要因、障壁、機会）
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析

■インフルエンザ診断の主要企業プロフィール動向

3M
Abbott
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
BIOMÉRIEUX
Bio-Rad Laboratories, Inc.
Goldsite Diagnostics, Inc.
Hologic, Inc.
DiaSorin S.p.A.
Meridian Bioscience, Inc.
QuidelOrtho Corporation
SA Scientific Ltd.
Sekisui Diagnostics
Siemens Healthineers
Thermo Fisher Scientific

（全172頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
3. Executive Summary: Global Influenza Diagnostics Market
4. Market Overview

    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Influenza Diagnostics Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Epidemiology
    5.2. Reimbursement Scenario
    5.3. COVID-19 Pandemic Impact on Industry

6. Global Influenza Diagnostics Market Analysis and Forecast, by Flu Virus Type

    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Flu Virus Type, 2017–2031
        6.3.1. Type A
        6.3.2. Type B
    6.4. Market Attractiveness Analysis, by Flu Virus Type

7. Global Influenza Diagnostics Market Analysis and Forecast, by Test Type

    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Test Type, 2017–2031
        7.3.1. RT-PCR Tests
        7.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        7.3.3. Viral Culture
        7.3.4. Immunofluorescence Assays
        7.3.5. Serological Tests
        7.3.6. Others (LAMP, SAMBA, etc.)
    7.4. Market Attractiveness Analysis, by Test Type

8. Global Influenza Diagnostics Market Analysis and Forecast, by Product Type

    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Product Type, 2017–2031
        8.3.1. Kits & Reagents
        8.3.2. Instrument
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by Product Type

9. Global Influenza Diagnostics Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Diagnostic Centers
        9.3.3. Others (academics & research institutes, etc.)
    9.4. Market Attractiveness Analysis, by End-user

10. Global Influenza Diagnostics Market Analysis and Forecast, by Region

    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region

11. North America Influenza Diagnostics Market Analysis and Forecast

    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Flu Virus Type, 2017–2031
        11.2.1. Type A
        11.2.2. Type B
    11.3. Market Value Forecast, by Test Type, 2017–2031
        11.3.1. RT-PCR Tests
        11.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        11.3.3. Viral Culture
        11.3.4. Immunofluorescence Assays
        11.3.5. Serological Tests
        11.3.6. Others (LAMP, SAMBA, etc.)
    11.4. Market Value Forecast, by Product Type, 2017–2031
        11.4.1. Kits & Reagents
        11.4.2. Instrument
        11.4.3. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospitals
        11.5.2. Diagnostic Centers
        11.5.3. Others (academics & research institutes, etc.)
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Flu Virus Type
        11.7.2. By Test Type
        11.7.3. By Product Type
        11.7.4. By End-user
        11.7.5. By Country

12. Europe Influenza Diagnostics Market Analysis and Forecast

    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Flu Virus Type, 2017–2031
        12.2.1. Type A
        12.2.2. Type B
    12.3. Market Value Forecast, by Test Type, 2017–2031
        12.3.1. RT-PCR Tests
        12.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        12.3.3. Viral Culture
        12.3.4. Immunofluorescence Assays
        12.3.5. Serological Tests
        12.3.6. Others (LAMP, SAMBA, etc.)
    12.4. Market Value Forecast, by Product Type, 2017–2031
        12.4.1. Kits & Reagents
        12.4.2. Instrument
        12.4.3. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospitals
        12.5.2. Diagnostic Centers
        12.5.3. Others (academics & research institutes, etc.)
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Flu Virus Type
        12.7.2. By Test Type
        12.7.3. By Product Type
        12.7.4. By End-user
        12.7.5. By Country/Sub-region

13. Asia Pacific Influenza Diagnostics Market Analysis and Forecast

    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Flu Virus Type, 2017–2031
        13.2.1. Type A
        13.2.2. Type B
    13.3. Market Value Forecast, by Test Type, 2017–2031
        13.3.1. RT-PCR Tests
        13.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        13.3.3. Viral Culture
        13.3.4. Immunofluorescence Assays
        13.3.5. Serological Tests
        13.3.6. Others (LAMP, SAMBA, etc.)
    13.4. Market Value Forecast, by Product Type, 2017–2031
        13.4.1. Kits & Reagents
        13.4.2. Instrument
        13.4.3. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospitals
        13.5.2. Diagnostic Centers
        13.5.3. Others (academics & research institutes, etc.)
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Flu Virus Type
        13.7.2. By Test Type
        13.7.3. By Product Type
        13.7.4. By End-user
        13.7.5. By Country/Sub-region

14. Latin America Influenza Diagnostics Market Analysis and Forecast

    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Flu Virus Type, 2017–2031
        14.2.1. Type A
        14.2.2. Type B
    14.3. Market Value Forecast, by Test Type, 2017–2031
        14.3.1. RT-PCR Tests
        14.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        14.3.3. Viral Culture
        14.3.4. Immunofluorescence Assays
        14.3.5. Serological Tests
        14.3.6. Others (LAMP, SAMBA, etc.)
    14.4. Market Value Forecast, by Product Type, 2017–2031
        14.4.1. Kits & Reagents
        14.4.2. Instrument
        14.4.3. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospitals
        14.5.2. Diagnostic Centers
        14.5.3. Others (academics & research institutes, etc.)
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Flu Virus Type
        14.7.2. By Test Type
        14.7.3. By Product Type
        14.7.4. By End-user
        14.7.5. By Country/Sub-region

15. Middle East & Africa Influenza Diagnostics Market Analysis and Forecast

    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Flu Virus Type, 2017–2031
        15.2.1. Type A
        15.2.2. Type B
    15.3. Market Value Forecast, by Test Type, 2017–2031
        15.3.1. RT-PCR Tests
        15.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
        15.3.3. Viral Culture
        15.3.4. Immunofluorescence Assays
        15.3.5. Serological Tests
        15.3.6. Others (LAMP, SAMBA, etc.)
    15.4. Market Value Forecast, by Product Type, 2017–2031
        15.4.1. Kits & Reagents
        15.4.2. Instrument
        15.4.3. Others
    15.5. Market Value Forecast, by End-user, 2017–2031
        15.5.1. Hospitals
        15.5.2. Diagnostic Centers
        15.5.3. Others (academics & research institutes, etc.)
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Flu Virus Type
        15.7.2. By Test Type
        15.7.3. By Product Type
        15.7.4. By End-user
        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. 3M
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Abbott
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. F. Hoffmann-La Roche Ltd.
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Becton, Dickinson and Company
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. BIOMÉRIEUX
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Bio-Rad Laboratories, Inc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Goldsite Diagnostics Inc.
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Hologic, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. DiaSorin S.p.A.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Meridian Bioscience, Inc.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. QuidelOrtho Corporation
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. SA Scientific Ltd.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. Sekisui Diagnostics
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. Siemens Healthineers
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview
        16.3.15. Thermo Fisher Scientific
            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.15.2. Product Portfolio
            16.3.15.3. Financial Overview
            16.3.15.4. SWOT Analysis
            16.3.15.5. Strategic Overview

List of Tables

Table 01: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 02: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 03: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 04: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 05: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 06: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 07: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 08: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 09: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 10: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 11: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 12: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 13: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 14: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 15: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 16: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 17: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 18: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 19: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 20: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 23: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 24: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 25: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 26: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 27: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031

Table 28: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 29: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 30: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Influenza Diagnostics Market Size, by Flu Virus Type, 2022

Figure 02: Global Influenza Diagnostics Market Share (%), by Flu Virus Type, 2022

Figure 03: Global Influenza Diagnostics Market Size, by Test Type, 2022

Figure 04: Global Influenza Diagnostics Market Share (%), by Test Type, 2022

Figure 05: Global Influenza Diagnostics Market Size, by Product Type, 2022

Figure 06: Global Influenza Diagnostics Market Share (%), by Product Type, 2022

Figure 07: Global Influenza Diagnostics Market Size, by End-user, 2022

Figure 08: Global Influenza Diagnostics Market Share (%), by End-user, 2022

Figure 09: Global Influenza Diagnostics Market, by Region (2022 and 2031)

Figure 10: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 12: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022

Figure 13: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2031

Figure 14: Global Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023–2031

Figure 15: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 16: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 17: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2031

Figure 18: Global Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 19: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 20: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022

Figure 21: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2031

Figure 22: Global Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 23: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 24: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 25: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2031

Figure 26: Global Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 27: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031

Figure 28: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022

Figure 29: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2031

Figure 30: Global Influenza Diagnostics Market Attractiveness Analysis, by Region, 2023–2031

Figure 31: North America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 32: North America Influenza Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

Figure 33: North America Influenza Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

Figure 34: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 35: North America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031

Figure 36: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 37: North America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-31

Figure 38: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 39: North America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-31

Figure 40: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 41: North America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 42: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 43: Europe Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 44: Europe Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 45: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 46: Europe Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031

Figure 47: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 48: Europe Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031

Figure 49: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 50: Europe Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

Figure 51: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 52: Europe Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 53: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 54: Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 55: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 57: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031

Figure 58: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 59: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031

Figure 60: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 61: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

Figure 62: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 63: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 64: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 65: Latin America Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 66: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 67: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 68: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031

Figure 69: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 70: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031

Figure 71: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 72: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

Figure 73: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 74: Latin America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 75: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 76: Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 77: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 78: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031

Figure 79: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031

Figure 80: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 81: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031

Figure 82: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031

Figure 83: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

Figure 84: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 85: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

△ 一番上に戻る